Skip to main content
Caplight Logo









Unnatural Products

Unnatural Products

Private
Santa Cruz, CaliforniaHealthcare & Life Scienceshttps://www.unnaturalproducts.com/

Last Round

Series B

Mar 16, 2026

Total Funding Raised

$83M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Unnatural Products is a biotechnology company that offers a computational biology platform for engineering peptides aimed at traditionally undruggable targets, utilizing machine learning to optimize macrocyclic compounds and expedite the drug discovery process.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

macrocyclic peptidesdrug discovery platformoral therapeuticsAI drug discoveryundruggable targetsAI-guided designbiotech platformmolecular designoral bioavailabilitypharma partnershipin silico drug designcomputational biologypeptide engineeringdrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unnatural Products Comparables

Compare Unnatural Products with similar companies based on industry and business-model similarity.

Unnatural Products comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dayra Therapeutics
88%
Syneron Bio
88%
Vilya
86%

Unnatural Products Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 16, 2026
Series ADec 19, 2023
SeedSep 17, 2019

Key People

Founding team and executive leadership

Cameron Pye

CEO

Executive Team

Unnatural Products Investors

Notable investors and investment history

Unnatural Products investors
InvestorRounds
Rising Tide FundSeries A, Seed
Merck Global Health Innovation FundSeries B
Better VenturesSeries A, Seed
Blue Bear VenturesSeries A, Seed
GaingelsSeries A
ARTIS VenturesSeries B, Series A, Seed
Asset Management VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 36% MoM, reaching 2.4K.

  • Mar 16, 2026

    $45M round raised.

Unnatural Products Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unnatural Products Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unnatural Products's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Cruz, California
Employee Range68
Year Founded2016
Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?